{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:50:35Z","timestamp":1722127835692},"reference-count":11,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["YAKUGAKU ZASSHI"],"published-print":{"date-parts":[[2018,12,1]]},"DOI":"10.1248\/yakushi.18-00155-4","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T22:22:47Z","timestamp":1543616567000},"page":"1531-1536","source":"Crossref","is-referenced-by-count":3,"title":["Current Problems Associated with Overseas Health Products"],"prefix":"10.1248","volume":"138","author":[{"given":"Miou","family":"Toda","sequence":"first","affiliation":[{"name":"Division of Food Safety Information, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikako","family":"Uneyama","sequence":"additional","affiliation":[{"name":"Division of Food Safety Information, National Institute of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) European Food Safety Authority (EFSA). \u201cGuidance on the preparation and presentation of an application for authorisation of a novel food in the context of Regulation (EU) 2015\/2283.\u201d: \u3008https:\/\/www.efsa.europa.eu\/en\/efsajournal\/pub\/4594\u3009, cited 21 June, 2018."},{"key":"2","unstructured":"2) European Food Safety Authority (EFSA). \u201cGuidance on the preparation and presentation of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015\/2283.\u201d: \u3008https:\/\/www.efsa.europa.eu\/en\/efsajournal\/pub\/4590\u3009, cited 21 June, 2018."},{"key":"3","unstructured":"3) European Food Safety Authority (EFSA). \u201cAdministrative guidance on the submission of applications for authorisation of a novel food pursuant to Article 10 of Regulation (EU) 2015\/2283.\u201d: \u3008http:\/\/www.efsa.europa.eu\/en\/supporting\/pub\/1381e\u3009, cited 21 June, 2018."},{"key":"4","unstructured":"4) U.S. Food and Drug Administration (FDA). \u201cDraft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues.\u201d: \u3008http:\/\/www.fda.gov\/Food\/GuidanceRegulation\/GuidanceDocumentsRegulatoryInformation\/ucm257563.htm\u3009, cited 21 June, 2018."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Chatham-Stephens K., Taylor E., Chang A., Peterson A., Daniel J., Martin C., Deuster P., Noe R., Kieszak S., Schier J., Klontz K., Lewis L., <i>Drug Test. Anal.<\/i>, <b>9<\/b>, 68-74 (2017).","DOI":"10.1002\/dta.2036"},{"key":"6","unstructured":"6) Ministry of Health, Labour and Welfare (MHLW). \u201cSafety Alert: OxyElite Pro. (9 October 2013).\u201d: \u3008http:\/\/www.mhlw.go.jp\/stf\/houdou\/0000025767.html\u3009, cited 21 June, 2018."},{"key":"7","unstructured":"7) Ministry of Health, Labour and Welfare (MHLW). \u201cSafety Alert (Second): OxyElite Pro. (25 December 2013).\u201d: \u3008http:\/\/www.mhlw.go.jp\/stf\/houdou\/0000033542.html\u3009, cited 21 June, 2018."},{"key":"8","unstructured":"8) Ministry of Health, Labour and Welfare (MHLW). \u201cPress Release (10 January 2014).\u201d: \u3008http:\/\/www.mhlw.go.jp\/stf\/houdou\/0000034391.html\u3009, cited 21 June, 2018."},{"key":"9","unstructured":"9) U.S. Food and Drug Administration (FDA). \u201cStatement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom (14 November 2017).\u201d: \u3008https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm584970.htm\u3009, cited 21 June, 2018."},{"key":"10","unstructured":"10) U.S. Food and Drug Administration (FDA). \u201cStatement from FDA Commissioner Scott Gottlieb, M.D., on the agency&apos;s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse (6 February 2018).\u201d: \u3008https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm595622.htm\u3009, cited 21 June, 2018."},{"key":"11","unstructured":"11) U.S. Food and Drug Administration (FDA). \u201cFDA Investigates Multistate Outbreak of <i>Salmonella<\/i> Infections Linked to Products Reported to Contain Kratom (15 March 2018).\u201d: \u3008http:\/\/s2027422842.t.en25.com\/e\/es?s=2027422842&e=62483&elqTrackId=B1F0B909CCF90C71B9C490C37BFE6647&elq=726bfcafbfef4c07bb4b22ad24ecfd81&elqaid=2794&elqat=1\u3009, cited 21 June, 2018."}],"container-title":["YAKUGAKU ZASSHI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/138\/12\/138_18-00155-4\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T04:25:38Z","timestamp":1543638338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yakushi\/138\/12\/138_18-00155-4\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/yakushi.18-00155-4","relation":{},"ISSN":["0031-6903","1347-5231"],"issn-type":[{"value":"0031-6903","type":"print"},{"value":"1347-5231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]}}}